MCM
FURX

Montibus Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Montibus Capital Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$8.37M Buy
190,286
+43,840
+30% +$1.81M 0.9% 48
2013
Q2 		$4.99M Buy
+146,446
New +$5.14M 0.63% 64

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Montibus Capital Management's FURX Position: Q3 2013 in Review

Montibus Capital Management increased its FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) stake by 30% in Q3 2013, buying an estimated $1.81M and bringing the position to 190,286 shares worth $8.37M. The position accounts for 0.9% of the portfolio, ranked #48.

Montibus Capital Management first reported a position in FURX in Q2 2013 and has held it in 2 quarters since. 85 funds tracked by Wall St. Rank hold FURX as of Q3 2013.

  • Montibus Capital Management held 190,286 shares of FURIEX PHARMACEUTICALS INC COM STK (DE) worth $8.37M as of Q3 2013.
  • Montibus Capital Management bought 43,840 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2013, an estimated $1.81M.
  • FURIEX PHARMACEUTICALS INC COM STK (DE) made up 0.9% of Montibus Capital Management's portfolio in Q3 2013, its #48 holding.
  • Montibus Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and has held it in 2 quarters since.
  • 85 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2013.

Based on Montibus Capital Management's 13F filing for Q3 2013, filed 13 Nov 2013.